Ravi Agroceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
- Revenue Growth -99.62%
- Profit Growth -113.24%
- Ebitda 99.29%
- Net Worth -1.80%
- Total Assets -0.46%
About Ravi Agroceuticals
Ravi Agroceuticals Private Limited (RAPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 March 1999 and has a history of 25 years and ten months. Its registered office is in Nellore, Andhra Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.50 Cr.
Hemalatha Ravi and Ajay Ravi serve as directors at the Company.
Company Details
-
Location
Nellore, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01122AP1999PTC031424
-
Company No.
031424
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Mar 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Ravi Agroceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hemalatha Ravi | Managing Director | 01-Dec-2001 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Ravi | Director | 01-Dec-2001 | Current |
Financial Performance of Ravi Agroceuticals.
Ravi Agroceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.62% decrease. The company also saw a substantial fall in profitability, with a 113.24% decrease in profit. The company's net worth dipped by a decrease of 1.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ravi Agroceuticals?
In 2020, Ravi Agroceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹25.00 M
₹0
Charges Breakdown by Lending Institutions
- Indusind Bank Limited : 2.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Mar 2006 | Indusind Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Ravi Agroceuticals?
Unlock and access historical data on people associated with Ravi Agroceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravi Agroceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravi Agroceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.